BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 27885694)

  • 1. Pharmacokinetics and tolerability of a new formulation of omeprazole in the horse.
    Di Salvo A; Busechian S; Zappulla F; Marchesi MC; Pieramati C; Orvieto S; Boveri M; Predieri PG; Rueca F; Della Rocca G
    J Vet Pharmacol Ther; 2017 Aug; 40(4):348-355. PubMed ID: 27885694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of dose and diet on the pharmacokinetics of omeprazole in the horse.
    Sykes BW; Underwood C; McGowan CM; Mills PC
    J Vet Pharmacol Ther; 2017 Apr; 40(2):172-178. PubMed ID: 27478135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of intravenous, plain oral and enteric-coated oral omeprazole in the horse.
    Sykes BW; Underwood C; McGowan CM; Mills PC
    J Vet Pharmacol Ther; 2015 Apr; 38(2):130-6. PubMed ID: 25271390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of paste and suspension formulations of omeprazole in the healing of gastric ulcers in racehorses in active training.
    Nieto JE; Spier S; Pipers FS; Stanley S; Aleman MR; Smith DC; Snyder JR
    J Am Vet Med Assoc; 2002 Oct; 221(8):1139-43. PubMed ID: 12387383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition of the anti-ulcer medications ranitidine, cimetidine, and omeprazole following administration of multiple doses to exercised Thoroughbred horses.
    Knych HK; Stanley SD; Arthur RM; McKemie DS
    J Vet Pharmacol Ther; 2017 Jan; 40(1):92-96. PubMed ID: 27292271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and bioequivalence testing of five commercial formulations of omeprazole in the horse.
    Sykes BW; Underwood C; Greer R; McGowan CM; Mills PC
    J Vet Pharmacol Ther; 2016 Feb; 39(1):78-83. PubMed ID: 25989292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of orally administered omeprazole in children. International Pediatric Omeprazole Pharmacokinetic Group.
    Andersson T; Hassall E; Lundborg P; Shepherd R; Radke M; Marcon M; Dalväg A; Martin S; Behrens R; Koletzko S; Becker M; Drouin E; Göthberg G
    Am J Gastroenterol; 2000 Nov; 95(11):3101-6. PubMed ID: 11095324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of feeding on the pharmacokinetic variables of two commercially available formulations of omeprazole.
    Sykes BW; Underwood C; McGowan CM; Mills PC
    J Vet Pharmacol Ther; 2015 Oct; 38(5):500-3. PubMed ID: 25676888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic comparison of omeprazole capsules and a simplified omeprazole suspension.
    Song JC; Quercia RA; Fan C; Tsikouris J; White CM
    Am J Health Syst Pharm; 2001 Apr; 58(8):689-94. PubMed ID: 11329761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pharmacokinetic study comparing single and repeated oral doses of 20 mg and 40 mg omeprazole and its two optical isomers, S-omeprazole (esomeprazole) and R-omeprazole, in healthy subjects.
    Hassan-Alin M; Andersson T; Niazi M; Röhss K
    Eur J Clin Pharmacol; 2005 Jan; 60(11):779-84. PubMed ID: 15578172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of oral omeprazole in llamas.
    Poulsen KP; Smith GW; Davis JL; Papich MG
    J Vet Pharmacol Ther; 2005 Dec; 28(6):539-43. PubMed ID: 16343286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of dose and diet on the pharmacodynamics of omeprazole in the horse.
    Sykes BW; Underwood C; Greer R; McGowan CM; Mills PC
    Equine Vet J; 2017 Jul; 49(4):525-531. PubMed ID: 27554924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of a paste formulation of omeprazole for the treatment of naturally occurring gastric ulcers in training standardbred racehorses in Canada.
    Doucet MY; Vrins AA; Dionne R; Alva R; Ericsson G
    Can Vet J; 2003 Jul; 44(7):581-5. PubMed ID: 12892289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative bioavailability of two oral formulations of omeprazole.
    Flores-Murrieta FJ; Carrasco-Portugal Mdel C; Reyes-García G; Medina-Santillán R; Herrera JE
    Proc West Pharmacol Soc; 2009; 52():18-20. PubMed ID: 22128412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variable omeprazole kinetics in healthy Jordanian adults.
    Albsoul-Younes A; Tayyem R; Najib N
    Biopharm Drug Dispos; 2005 Jul; 26(5):183-8. PubMed ID: 15906422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of orally administered enteric-coated omeprazole on gastric acid secretion in horses.
    Andrews FM; Doherty TJ; Blackford JT; Nadeau JA; Saxton AM
    Am J Vet Res; 1999 Aug; 60(8):929-31. PubMed ID: 10451198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic interaction between darunavir boosted with ritonavir and omeprazole or ranitidine in human immunodeficiency virus-negative healthy volunteers.
    Sekar VJ; Lefebvre E; De Paepe E; De Marez T; De Pauw M; Parys W; Hoetelmans RM
    Antimicrob Agents Chemother; 2007 Mar; 51(3):958-61. PubMed ID: 17210768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of Roux-en-Y Gastric Bypass Surgery in Morbidly Obese Patients on Pharmacokinetics of (Acetyl)Salicylic Acid and Omeprazole: the ERY-PAO Study.
    Mitrov-Winkelmolen L; van Buul-Gast MW; Swank DJ; Overdiek HWPM; van Schaik RHN; Touw DJ
    Obes Surg; 2016 Sep; 26(9):2051-2058. PubMed ID: 26797705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot study comparing the effect of orally administered esomeprazole and omeprazole on gastric fluid pH in horses.
    Huxford KE; Dart AJ; Perkins NR; Bell R; Jeffcott LB
    N Z Vet J; 2017 Nov; 65(6):318-321. PubMed ID: 28738738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of intrarectal omeprazole in alpacas.
    Marmulak T; Stanley S; Kass PH; Wiebe V; McKemie D; Pusterla N
    J Vet Pharmacol Ther; 2010 Aug; 33(4):371-5. PubMed ID: 20646199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.